WAYNE, Pa. (AP) _ Aevi Genomic Medicine Inc. (GNMX) on Thursday reported a loss of $7.2 million in its third quarter.
On a per-share basis, the Wayne, Pennsylvania-based company said it had a loss of 12 cents.
The company's shares closed at $1.09. A year ago, they were trading at $1.66.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNMX at https://www.zacks.com/ap/GNMX